At ASMS 2025, the Technology Networks team caught up with Jim Langridge, Director, Advanced MS Technologies & Scientific Fellow at Waters, who shared exciting recent developments in mass spectrometry.

Using CRISPR gene editing, researchers revealed a combination of therapies that showed promise in treating cancer in ...

Researchers have identified alpha and delta brain waves as biomarkers for OCD, offering new insight into compulsive behavior.

This article explores how mass spectrometry and emerging analytical techniques are helping researchers decode the aging ...

Researchers at the Max Perutz Labs have uncovered a new mitophagy pathway that functions independently of FIP200, a protein ...

Researchers found that PFAS exposure in firefighters alters microRNAs tied to cancer and other diseases. Analyzing blood ...

Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...

By encapsulating magnetic particles in lipid vesicles, researchers have created microscopic drug delivery containers which ...

A study by the Hospital del Mar Research Institute and Yale University reveals that genes linked to autism, schizophrenia and ...

Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in ...

Researchers have discovered that when photoreceptor cells in the retina are damaged, microglia, or the brain’s immune cells, ...

GLP-1 drugs may reduce asthma symptoms in obese adults, offering a steroid-free alternative to treatment. The study includes ...